China Health Group Inc. (8225.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 130.53M |
| Enterprise Value | 107.09M |
| P/E Ratio | -2.73 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 1.33 |
| Price/Book Ratio | 0.9 |
| Enterprise/Revenue | 0.56 |
| Enterprise/EBITDA | 7.96 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.22 |
| Operating Margin | 0.22 |
AD
Management Effectiveness
| Return On Assets | -0.1 |
| Return On Equity | -0.15 |
Income Statement
| Revenue | 27.82M |
| Revenue/Share | 0.04 |
| Gross Profit | 15.97M |
| EBITDA | -14.05M |
| Net Income | -14.57M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 35.57M |
| Total Cash/Share | 0.04 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.55 |
| Book Value Per Share | 0.06 |
Price History
| 52-Week Change | -56.88 |
| 52-Week High | 0.16 |
| 52-Week Low | 0.07 |
| Moving Average 50 Days | 0.08 |
| Moving Average 200 Days | 0.11 |
Statistics
| Average Volume | 72,811 |
| Shares Outstanding | 995.35M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 747:500 |
| Last Split Date | October 13, 2014 |
AD
